JP2004502732A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502732A5 JP2004502732A5 JP2002508437A JP2002508437A JP2004502732A5 JP 2004502732 A5 JP2004502732 A5 JP 2004502732A5 JP 2002508437 A JP2002508437 A JP 2002508437A JP 2002508437 A JP2002508437 A JP 2002508437A JP 2004502732 A5 JP2004502732 A5 JP 2004502732A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- inhibiting
- alkyl
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 150000001875 compounds Chemical group 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 208000011581 secondary neoplasm Diseases 0.000 description 2
- IPBCWPPBAWQYOO-UHFFFAOYSA-N 2-(tetradecylthio)acetic acid Chemical compound CCCCCCCCCCCCCCSCC(O)=O IPBCWPPBAWQYOO-UHFFFAOYSA-N 0.000 description 1
- LUQGQZIVDLUXLE-UHFFFAOYSA-N CCCCCCCCCCCCCCCC(O)=[Se] Chemical compound CCCCCCCCCCCCCCCC(O)=[Se] LUQGQZIVDLUXLE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 150000004673 fluoride salts Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20003591A NO20003591L (no) | 2000-07-13 | 2000-07-13 | Fettsyreanaloger for behandling av kreft |
| PCT/NO2001/000301 WO2002003983A1 (en) | 2000-07-13 | 2001-07-13 | Fatty acid analogues for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004502732A JP2004502732A (ja) | 2004-01-29 |
| JP2004502732A5 true JP2004502732A5 (enExample) | 2008-08-14 |
Family
ID=19911376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002508437A Pending JP2004502732A (ja) | 2000-07-13 | 2001-07-13 | 癌治療のための脂肪酸類似体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7378443B2 (enExample) |
| EP (1) | EP1313463B1 (enExample) |
| JP (1) | JP2004502732A (enExample) |
| KR (2) | KR20080071598A (enExample) |
| CN (1) | CN100569228C (enExample) |
| AT (1) | ATE320802T1 (enExample) |
| AU (2) | AU7286001A (enExample) |
| BR (1) | BR0112399A (enExample) |
| CA (1) | CA2414480A1 (enExample) |
| DE (1) | DE60118198T2 (enExample) |
| ES (1) | ES2261441T3 (enExample) |
| MX (1) | MXPA02012944A (enExample) |
| NO (2) | NO20003591L (enExample) |
| NZ (1) | NZ523316A (enExample) |
| RU (1) | RU2283105C2 (enExample) |
| WO (1) | WO2002003983A1 (enExample) |
| ZA (1) | ZA200210028B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO328803B1 (no) | 2000-03-03 | 2010-05-18 | Thia Medica | Nye fettsyreanaloger |
| RU2331649C2 (ru) | 2002-06-20 | 2008-08-20 | Ай-Си Ви-И-Си Лимитед | Серосодержащие фосфолипидные производные, содержащая их фармацевтическая композиция, их применение для лечения заболеваний и способ их получения |
| EP1784223A2 (en) | 2004-07-19 | 2007-05-16 | Thia Medica AS | Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| NO20053519L (no) * | 2005-07-18 | 2007-01-19 | Thia Medica As | Anvendelse av forbindelser som omfatter fettsyrer |
| US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
| US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
| WO2010033878A2 (en) | 2008-09-19 | 2010-03-25 | David Brown | Solute concentration measurement device and related methods |
| US20110152770A1 (en) | 2009-07-30 | 2011-06-23 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
| US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| EP2983658B1 (en) | 2013-03-11 | 2024-05-01 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
| AU2014229506B2 (en) | 2013-03-11 | 2017-04-13 | Nobesita As | Natural lipids containing non-oxidizable fatty acids |
| US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
| DE102014116958B9 (de) * | 2014-11-19 | 2017-10-05 | Trumpf Laser- Und Systemtechnik Gmbh | Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung |
| BR112017026709A2 (pt) * | 2015-06-11 | 2018-08-28 | Univ Miami | tratamento e diagnóstico de câncer |
| CN105498622B (zh) * | 2015-12-10 | 2017-10-17 | 江南大学 | 一种含硒表面活性剂及其制备方法和应用 |
| CN107235880B (zh) * | 2017-06-30 | 2018-10-30 | 江南大学 | 一种含硒阳离子表面活性剂及其应用 |
| GB201910644D0 (en) * | 2019-07-25 | 2019-09-11 | Coegin Pharma As | Cancer Treatment |
| ES3041492T3 (en) | 2019-12-18 | 2025-11-12 | Stinginn Llc | Substituted 1,2, 4-triazoles and methods of use |
| US11897888B1 (en) | 2020-04-30 | 2024-02-13 | Stinginn Llc | Small molecular inhibitors of sting signaling compositions and methods of use |
| CN115260964A (zh) * | 2022-08-29 | 2022-11-01 | 烟台市福山义昌精细化工厂 | 一种石油油管丝扣专用密封胶及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0686377B2 (ja) * | 1985-09-30 | 1994-11-02 | 日清製粉株式会社 | がん転移抑制剤 |
| SE9103572D0 (sv) * | 1991-11-29 | 1991-11-29 | Astra Ab | Organic salts of n,n'-diacetyl cystine |
| JPH0797320A (ja) * | 1993-08-04 | 1995-04-11 | Takuma Sasaki | 制癌剤 |
| US6358915B1 (en) * | 1995-03-07 | 2002-03-19 | George Washington University | Methods for inhibiting metastasis |
| US5750515A (en) * | 1995-04-10 | 1998-05-12 | Taiho Pharmaceutical Co., Ltd. | Cancer metastasis inhibitor |
| NO952796D0 (no) * | 1995-07-14 | 1995-07-14 | Rolf Berge | Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater |
| DE69726182T2 (de) * | 1996-12-11 | 2004-08-12 | Dana-Farber Cancer Institute, Inc., Boston | Methoden und pharmazeutische zusammenstellungen zur wachstumsverhinderung von tumorzellen enthaltend einen ppar-gamma agonisten und einen map kinase inhibitor |
| DE19700774A1 (de) * | 1997-01-13 | 1998-07-16 | Hoechst Ag | Antiadhäsive Sulfatid-Mimetika |
| AU7240398A (en) * | 1998-05-08 | 1999-11-29 | Rolf Berge | Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions |
| JP4993878B2 (ja) * | 2005-06-28 | 2012-08-08 | ダイキョーニシカワ株式会社 | 多気筒エンジンの吸気装置 |
-
2000
- 2000-07-13 NO NO20003591A patent/NO20003591L/no not_active Application Discontinuation
-
2001
- 2001-07-13 KR KR1020087014318A patent/KR20080071598A/ko not_active Withdrawn
- 2001-07-13 NZ NZ523316A patent/NZ523316A/en not_active IP Right Cessation
- 2001-07-13 AT AT01952065T patent/ATE320802T1/de not_active IP Right Cessation
- 2001-07-13 KR KR1020037000477A patent/KR100861428B1/ko not_active Expired - Fee Related
- 2001-07-13 CA CA002414480A patent/CA2414480A1/en not_active Abandoned
- 2001-07-13 BR BR0112399-8A patent/BR0112399A/pt not_active Application Discontinuation
- 2001-07-13 WO PCT/NO2001/000301 patent/WO2002003983A1/en not_active Ceased
- 2001-07-13 AU AU7286001A patent/AU7286001A/xx active Pending
- 2001-07-13 RU RU2002134754/15A patent/RU2283105C2/ru not_active IP Right Cessation
- 2001-07-13 CN CNB018127177A patent/CN100569228C/zh not_active Expired - Fee Related
- 2001-07-13 ES ES01952065T patent/ES2261441T3/es not_active Expired - Lifetime
- 2001-07-13 EP EP01952065A patent/EP1313463B1/en not_active Expired - Lifetime
- 2001-07-13 DE DE60118198T patent/DE60118198T2/de not_active Expired - Fee Related
- 2001-07-13 MX MXPA02012944A patent/MXPA02012944A/es active IP Right Grant
- 2001-07-13 US US10/312,901 patent/US7378443B2/en not_active Expired - Fee Related
- 2001-07-13 AU AU2001272860A patent/AU2001272860B2/en not_active Ceased
- 2001-07-13 JP JP2002508437A patent/JP2004502732A/ja active Pending
-
2002
- 2002-12-11 ZA ZA200210028A patent/ZA200210028B/en unknown
- 2002-12-11 NO NO20025930A patent/NO324634B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004502732A5 (enExample) | ||
| JP2003509349A5 (enExample) | ||
| EP0909560A3 (en) | Treatment o tumors with compounds having RXR retinoid receptor agoinst activity | |
| EP2792353A3 (en) | Compounds and methods for delivery of prostacyclin analogs | |
| BR0115910A (pt) | Compostos orgânicos | |
| JP2001526218A5 (enExample) | ||
| RU2006144123A (ru) | Новые энантиомерночистые в-агонисты, способ их получения и их применение в качестве лекарственных средств | |
| RU2000132188A (ru) | Производные эпотилонов, их синтез и применение | |
| RU94044671A (ru) | Применение непептидных антагонистов рецептора тахикинина | |
| RU2002134754A (ru) | Аналоги жирных кислот для лечения рака | |
| JP2004517843A5 (enExample) | ||
| JP2002519425A5 (enExample) | ||
| NO20055655L (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
| JP2002537258A5 (enExample) | ||
| EP1177791A3 (en) | Use of glycogen phosphorylase inhibitors to inhibit tumor growth | |
| DE60014916D1 (de) | Die Verwendung eines Benzimidazoles zur Herstellung eines Medikamentes zur Krebsvorbeugung | |
| TW200602035A (en) | [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase | |
| CA2660939A1 (en) | Pharmaceutical compositions for the treatment of fungal infections | |
| RU94045156A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования преждевременного полового созревания | |
| WO2008094912B1 (en) | Substituted gamma lactams as therapeutic agents | |
| PL367340A1 (en) | Quinoline derivatives and use thereof as antitumor agents | |
| JP2010516817A5 (enExample) | ||
| ATE358128T1 (de) | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation | |
| JP2007525533A5 (enExample) | ||
| JP2006096734A5 (enExample) |